Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

Weitere Dokumente

N176

Sigma-Aldrich

Naloxonazine dihydrochloride hydrate

powder, ≥95% (HPLC)

Synonym(e):

bis[(5α)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazone hydrate dihydrochloride

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C38H42N4O6 · 2HCl · xH2O
CAS-Nummer:
880759-65-9
Molekulargewicht:
723.69 (anhydrous basis)
UNSPSC-Code:
12352200
PubChem Substanz-ID:
24278602
NACRES:
NA.77

Assay

≥95% (HPLC)

Form

powder

Arzneimittelkontrolle

regulated under CDSA - not available from Sigma-Aldrich Canada

Lagerbedingungen

desiccated

Farbe

off-white to light tan

Löslichkeit

H2O: >2 mg/mL

Lagertemp.

−20°C

SMILES String

O.Cl.Cl.CC(=C)CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CC\C4=N/N=C6\CC[C@@]7(O)[C@H]8Cc9ccc(O)c%10O[C@@H]6[C@]7(CCN8CC=C)c9%10)c35

InChI

1S/C39H44N4O6.2ClH.H2O/c1-4-15-42-16-13-36-30-22-5-7-26(44)32(30)48-34(36)24(9-11-38(36,46)28(42)18-22)40-41-25-10-12-39(47)29-19-23-6-8-27(45)33-31(23)37(39,35(25)49-33)14-17-43(29)20-21(2)3;;;/h4-8,28-29,34-35,44-47H,1-2,9-20H2,3H3;2*1H;1H2/b40-24+,41-25+;;;/t28-,29-,34+,35+,36+,37+,38-,39-;;;/m1.../s1

InChIKey

FZEFFWGHDWIOOD-VCOBIVQDSA-N

Angaben zum Gen

human ... OPRM1(4988)

Biochem./physiol. Wirkung

Potent opioid antagonist that is selective for μ1 opioid receptors.

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

R A Cruciani et al.
The Journal of pharmacology and experimental therapeutics, 242(1), 15-20 (1987-07-01)
The authors have characterized the opioid receptors of rat brain membranes using self- and cross-displacement studies with both tritiated and unlabeled [D-Ala2, D-Leu5]-enkephalin and [D-Ala2, MePhe4, Gly-ol5]-enkephalin. Mathematical modeling demonstrated the presence of three classes of binding sites, corresponding to
C G Pick et al.
Life sciences, 48(21), 2005-2011 (1991-01-01)
beta-Funaltrexamine (beta-FNA) irreversibly blocks morphine analgesia, lethality and its inhibition of gastrointestinal transit, confirming that these actions involve mu receptors. In dose-response studies, beta-FNA antagonized all the actions with similar potencies (ID50 values of 12.1, 11.3 and 12.3 mg/kg, respectively).
Esmaeal Tamaddonfard et al.
Veterinary research forum : an international quarterly journal, 8(1), 29-34 (2017-05-06)
The parafascicular nucleus (PFN) of thalamus, as a supraspinal structure, has an important role in processing of nociceptive information. In addition, μ-opioid receptor contributes to supraspinal modulation of nociception. In the present study, the effects of microinjection of naloxone (a
Amir Erfanparast et al.
Physiology & behavior, 170, 68-77 (2016-12-22)
In the present study, we investigated the effects of microinjection of vitamin B
S Sakurada et al.
Brain research, 881(1), 1-8 (2000-10-18)
To determine the role of spinal mu-opioid receptor subtypes in antinociception induced by intrathecal (i.t.) injection of endomorphin-1 and -2, we assessed the effects of beta-funaltrexamine (a selective mu-opioid receptor antagonist) naloxonazine (a selective antagonist at the mu(1)-opioid receptor) and
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.